Current trends of the changes of the etiological structure and clinical and laboratory characteristics of hepatocellular carcinoma

Abstract

The etiological structure of chronic viral hepatitides with the outcome in hepatocellular carcinoma (HCC) was studied among deceased patients for the periods of 1986-1998 and 2002-2012 in total and in comparison. HCC developed as the outcome of CHB in 45.0% of patients, CHC - in 20.7 % , CHB+C - 18,6%, CVHN- in 12.9%, CHB + D - 1.4%, CHB+C+D - also in 1.4% of patients. When comparing the data for 1986-1998 (13 years), and 2002-2012 (11 years) there was noticed an increase in the number of deaths from HCC (2-fold), there was significantly increased the incidence of HCC, associated with CHC (from 2.0% to 30.8 %), nonverified chronic hepatitis as a cause of HCC occurred 6.5 times less often (28.6 % - 4.4%), the number of cases of HCC, caused by CHB, became lower (49.0 % - 42.9 %), CHB+C - almost unchanged (20.4% - 17.6 % ). A presumptive middle time of the development of HCC since infection with hepatitis viruses is 27,6 ± 9,8 years. In assessing the cofactors ofprogression of HCC there was found that alcohol abuse occurred in 38.5 % ofpatients, diabetes - in 18,7%, HIV- infection -in 3.3%.

Keywords

hepatocellular carcinoma / chronic viral hepatitides / Saint Petersburg

References

[1] Кучерявый Ю.А., Стукова Н.Ю., Ахтаева Н.Л. Хронический гепатит, цирроз печени и гепатоцеллюлярная карцинома - звенья одной цепи. Клинические перспективы гастроэнтерологии, гепатологии. 2012; 5: 3-11.

[2] Мерабишвили В.М. Онкологическая служба Санкт-Петербурга (оперативная отчетность за 2011-2012 годы). Популяционный раковый регистр. СПб; 2013; т. 18.

[3] Ярошенко Е.Б., Бурневич Э.З., Мойсюк Я.Г. Роль вирусных гепатитов в развитии гепатоцеллюлярной карциномы. Практическая онкология. 2008; 4: 189-93.

[4] Гепатоцеллюлярная карцинома (ГЦК): глобальная перспектива. Практические рекомендации Всемирной гастроэнтерологической организации / Ferenzi P., Fried M., labrecque D. et al. 2009.

[5] Van Nieuwkerk C.M.J., Raws E.A.J., Tytgat G.N.J., Reeders J.W.A.J., Jones A.E., Gouma D.J. Диагностика и лечение гепатоцеллюлярной карциномы: новые подходы. Ned Tijdschr Geneeskd 1996, 140/171: 922-6. Available at: http//www.rmj.ru/ articles_2665.htm

[6] Патютко Ю.И., Сагайдак И.В., Чугуев Е.С., Гахраманов А.Д., Поляков А.Н. Гепатоцеллюлярный рак печени. Бюллетень медицинских интернет-конференций. 2011. 1 (6): 35-61. Available at: cyberleninka.ru

[7] Constantin C.V., Streba C.T., Pogoveanu I., Nita-Stefanescu L., Ionescu A.G. Cirrhosis and chronic viral hepatitis as risk factors for hepatocellular carcinoma: Romanian single-clinic experience. Mædica - J. Clin. Med. 2010; 4: 265-70.

[8] Cordoba-Relloza I. Hepatocellular carcinoma. Available at: www.hcvadvocate.org/hcsp/articles/rellosa.html

[9] Lin C.-W., Lin C.-C., MoL.-R., Chang C.-Y., Perng D.-S., Chia- Chang Hsu C.-C et al. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis. J. Hepatol. 2013. 58 (4): 730-5.

[10] Michielson P.P., Francque S.M., vanDongen J.L. Viral hepatitis and hepatocellular carcinoma: review. World J. Surg. Oncol. 2005; 3: 27.

[11] Altavilla G., Caputo A., Lanfredi M., Piola C., Borbanti-Brodano G., Corallini A Enhancement of chemical hepatocarcinogen-esis by the HIV-1 tat gene. Am. J. Pathol. 2000; 157: 1081-9.

[12] Brau N., Fox R.K. Xiao P et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S. - Canadian multicenter study. J. Hepatol. 2007; 47: 527-37.

[13] Joshi D., O’Grady J., Dieterich D., Gazzard B., Agarwal K. Increasing burden of liver disease in patients with HIV-infection. lancet. 2011; 2; 377 (9772): 1198-209.

[14] Macdonald D.C., Nelson M., Bower M., Powles T. Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era. World J. Gastroenterol. 2008; 14 (11): 1657-63.

[15] Pineda J.A., Garcia-Garcia J.A., Aguilar-Guisado M. et al. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology. 2007; 46: 622-30.

[16] Puoti M., Bruno R., Soriano V. et al. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AlDs. 2004; 18: 2285-93.

[17] El-Serag H.B., Marrero J.A., Rudolph L., Reddly K.R. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008; 134 (6): 1752-63.

[18] Карев В.Е., Цинзерлинг В.А., Комарова Д.В., Яковлев А.А. Связь хронического вирусного гепатита и гепатоцеллюлярного рака. Вопросы онкологии. 2000; 46 (4): 427-32.

RIGHTS & PERMISSIONS

Eco-vector